tiprankstipranks
Trending News
More News >
Kanoria Chemicals & Industries Ltd (IN:KANORICHEM)
:KANORICHEM
India Market
Advertisement

Kanoria Chemicals & Industries Ltd (KANORICHEM) AI Stock Analysis

Compare
0 Followers

Top Page

IN:KANORICHEM

Kanoria Chemicals & Industries Ltd

(KANORICHEM)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 4o)
Rating:45Neutral
Price Target:
₹78.00
▲(0.10% Upside)
Kanoria Chemicals & Industries Ltd faces significant financial challenges, with persistent net losses and increasing debt levels impacting its financial performance. The technical analysis indicates a bearish trend, and the valuation is unattractive due to a negative P/E ratio and lack of dividend yield. These factors contribute to a moderate risk profile, requiring strategic improvements for better financial health.

Kanoria Chemicals & Industries Ltd (KANORICHEM) vs. iShares MSCI India ETF (INDA)

Kanoria Chemicals & Industries Ltd Business Overview & Revenue Model

Company DescriptionKanoria Chemicals & Industries Limited manufactures and sells chemical intermediates in India. The company operates through Alco Chemicals and Solar Power segments. It provides chemicals, such as acetaldehyde, di-pentaerythritol, formaldehyde, hexamine, pentaerythritol, phenolic resins, and sodium formate. The company also develops and sells electronic and mechatronic modules, and control devices for the automotive, consumer goods, power tool electronics, and building automation industries. In addition, it operates a solar power plant with a generation capacity of 5 MW in Jodhpur district, Rajasthan; and manufactures and sells yarn and denim. The company also exports its products. The company was incorporated in 1960 and is based in New Delhi, India. Kanoria Chemicals & Industries Limited is a subsidiary of Vardhan Limited.
How the Company Makes MoneyKANORICHEM generates revenue through multiple key streams, primarily by manufacturing and selling specialty chemicals to diverse industries. The company's revenue model is based on the production of high-value chemical products that cater to specific industry needs, allowing them to command premium pricing. Significant revenue is derived from long-term contracts and repeat business with established clients in the textile and pharmaceutical sectors. Additionally, KANORICHEM benefits from strategic partnerships with other manufacturers and distributors, enhancing its market reach and operational efficiency. The company's focus on research and development also enables it to innovate and introduce new products, which further drives revenue growth.

Kanoria Chemicals & Industries Ltd Financial Statement Overview

Summary
Kanoria Chemicals & Industries Ltd is facing financial challenges characterized by fluctuating revenues, persistent net losses, and increasing debt levels. While there are signs of operational improvement, the company must focus on enhancing profitability, reducing leverage, and improving cash flows to ensure long-term financial health. The current financial position indicates moderate risk, requiring strategic management actions to stabilize performance.
Income Statement
45
Neutral
Kanoria Chemicals & Industries Ltd shows fluctuating revenue with a recent decline from 2023 to 2024, followed by a slight increase in 2025. The gross profit margin has improved, yet the company has been experiencing net losses in recent years, with net income turning negative. This indicates challenges in cost management and profitability. The EBIT margin has been volatile and negative in 2024, but improved slightly in 2025, suggesting some operational recovery.
Balance Sheet
50
Neutral
The company maintains a moderate debt-to-equity ratio, increasing from previous years, which indicates a rise in leverage. The equity ratio is relatively stable, showing a consistent level of equity financing. However, declining stockholders' equity and increased debt levels pose a risk to financial stability. Return on equity has turned negative recently due to net losses, affecting investor returns.
Cash Flow
40
Negative
Free cash flow has been negative, indicating the company is facing challenges generating cash after capital expenditures. The operating cash flow to net income ratio suggests a reliance on non-operating activities for cash generation, as net income remains negative. The company needs to improve cash generation to support operations and reduce financial strain.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue16.06B15.37B14.75B15.78B13.69B10.95B
Gross Profit4.93B4.71B4.67B4.62B3.86B3.44B
EBITDA456.20M313.70M642.63M826.90M955.19M1.01B
Net Income-745.90M-836.00M-383.96M-87.70M68.26M145.23M
Balance Sheet
Total Assets0.0014.98B14.90B14.81B14.03B13.62B
Cash, Cash Equivalents and Short-Term Investments109.60M109.60M141.07M308.20M314.68M348.06M
Total Debt0.005.95B5.09B5.10B4.75B4.93B
Total Liabilities-5.10B9.88B8.73B8.74B8.01B7.66B
Stockholders Equity5.10B5.21B6.01B6.05B5.98B5.87B
Cash Flow
Free Cash Flow0.00-800.10M-432.20M-317.60M402.19M548.15M
Operating Cash Flow0.00202.80M375.70M257.20M830.76M824.60M
Investing Cash Flow0.00-648.70M-503.50M-249.80M-431.08M-118.15M
Financing Cash Flow0.00414.60M51.40M34.49M-530.48M-749.09M

Kanoria Chemicals & Industries Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price77.92
Price Trends
50DMA
81.62
Negative
100DMA
86.29
Negative
200DMA
88.94
Negative
Market Momentum
MACD
-1.15
Positive
RSI
41.25
Neutral
STOCH
23.97
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KANORICHEM, the sentiment is Negative. The current price of 77.92 is below the 20-day moving average (MA) of 79.69, below the 50-day MA of 81.62, and below the 200-day MA of 88.94, indicating a bearish trend. The MACD of -1.15 indicates Positive momentum. The RSI at 41.25 is Neutral, neither overbought nor oversold. The STOCH value of 23.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:KANORICHEM.

Kanoria Chemicals & Industries Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
₹2.28B23.10
70
Outperform
₹1.61B15.378.72%-76.65%-76.77%
69
Neutral
₹9.95B117.542.99%45.22%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
₹5.61B38.1930.63%
45
Neutral
₹3.37B-4.5010.07%-35.05%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:KANORICHEM
Kanoria Chemicals & Industries Ltd
77.92
-51.48
-39.78%
IN:CENTEXT
Century Extrusions Ltd
27.39
4.28
18.52%
IN:DIAMINESQ
Diamines & Chemicals Ltd.
263.30
-287.88
-52.23%
IN:LORDSCHLO
Lords Chloro Alkali Limited
219.35
82.40
60.17%
IN:MAHASTEEL
Mahamaya Steel Industries Ltd.
666.80
444.50
199.96%
IN:OCCL
Oriental Carbon & Chemicals Ltd
160.55
-94.45
-37.04%

Kanoria Chemicals & Industries Ltd Corporate Events

Kanoria Chemicals Announces Trading Window Closure
Sep 19, 2025

Kanoria Chemicals & Industries Ltd has announced the closure of its trading window in compliance with SEBI regulations, effective from October 1, 2025, until the financial results for the quarter and half-year ending September 30, 2025, are declared. This move is aimed at preventing insider trading by designated persons during this period, ensuring transparency and compliance with regulatory standards.

Kanoria Chemicals Announces 65th AGM Details
Sep 3, 2025

Kanoria Chemicals & Industries Ltd has announced the publication of advertisements in newspapers regarding its 65th Annual General Meeting, including details on e-voting facilities. This announcement is part of the company’s compliance with regulatory requirements, ensuring transparency and accessibility for its stakeholders.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 21, 2025